Search

Home > JAMA Network > JAMA Oncology : Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
Podcast: JAMA Network
Episode:

JAMA Oncology : Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
Category: Science & Medicine
Duration: 00:19:25
Publish Date: 2019-07-25 10:00:00
Description:

Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
Total Play: 0